MetLife Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Buy |
|
|||||
|
2025
Q1 | $2.83M | Sell |
|
|||||
|
2024
Q4 | $2.36M | Buy |
|
|||||
|
2024
Q3 | $2.07M | Hold |
|
|||||
|
2024
Q2 | $2.06M | Buy |
|
|||||
|
2024
Q1 | $1.83M | Sell |
|
|||||
|
2023
Q4 | $2.44M | Hold |
|
|||||
|
2023
Q3 | $1.59M | Hold |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $923K | Sell |
|
|||||
|
2022
Q4 | $445K | Hold |
|
|||||
|
2022
Q3 | $581K | Hold |
|
|||||
|
2022
Q2 | $531K | Hold |
|
|||||
|
2022
Q1 | $593K | Buy |
|
|||||
|
2021
Q4 | $639K | Hold |
|
|||||
|
2021
Q3 | $1.8M | Hold |
|
|||||
|
2021
Q2 | $2.34M | Buy |
|
|||||
|
2021
Q1 | $2.12M | Buy |
|
|||||
|
2020
Q4 | $2.12M | Sell |
|
|||||
|
2020
Q3 | $1.2M | Hold |
|
|||||
|
2020
Q2 | $1.05M | Hold |
|
|||||
|
2020
Q1 | $931K | Buy |
|
|||||
|
2019
Q4 | $359K | Sell |
|
|||||
|
2019
Q3 | $320K | Buy |
|